Healthcare Services

Cholesterol Testing Market (2026–2030): Industry Developments

April 20, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Cholesterol Test Market From 2026 To 2030?

The cholesterol test market size has demonstrated strong growth in recent years. It is anticipated to expand from $9.94 billion in 2025 to $10.8 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.7%. This expansion during the historic period can be linked to the increasing prevalence of cardiovascular diseases, a heightened awareness of cholesterol monitoring, the expansion of diagnostic laboratory networks, a rise in preventive healthcare screening, and the availability of affordable test kits.

The cholesterol test market size is anticipated to experience robust expansion over the next few years, set to reach $15.25 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.0%. This growth during the forecast period is attributed to the increasing demand for self-monitoring diagnostic tools, a rising focus on early disease detection, the expansion of remote patient testing solutions, the growing integration of digital health platforms, and the increasing adoption of personalized healthcare diagnostics. Major trends throughout the forecast period include the increasing uptake of home-based cholesterol testing kits, a rising demand for point-of-care lipid testing devices, the growing use of multi-parameter lipid panels, the expansion of preventive cardiovascular screening programs, and an enhanced focus on rapid and accurate test results.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/cholesterol-test-global-market-report

What Major Factors Are Driving The Cholesterol Test Market Forward?

The growing incidence of cardiovascular diseases is anticipated to fuel the expansion of the cholesterol test market. Cardiovascular diseases (CVDs) represent a spectrum of heart and blood vessel disorders, including conditions like coronary heart disease, stroke, peripheral arterial disease, and aortic disease. A cholesterol test furnishes individuals and healthcare providers with critical data concerning the likelihood of developing heart disease. For example, in August 2025, as per the National Institutes of Health, a US-based government agency, forecasts suggest that between 2025 and 2050, cardiovascular prevalence is expected to increase by 90%, mortality by 73%, and DALYs by 55%, with deaths escalating from 20.5 million to 35.6 million. Hence, the escalating prevalence and mortality rates from cardiovascular diseases will propel the cholesterol test market.

How Are Segments Identified Within The Cholesterol Test Market Segment Framework?

The cholesterol test market covered in this report is segmented –

1) By Product Type: Test Kits, Test Strips, Other Product Types

2) By Test Type: Total Cholesterol Test, High-Density Lipoprotein (HDL) Cholesterol, Low-Density Lipoprotein (LDL) Cholesterol, Triglycerides Or Very Low-Density Lipoprotein (VLDL) Cholesterol Test

3) By Distribution Channel: Over The Counter, Prescription Based

4) By End User: Hospitals, Diagnostic Centers, Other End-Users

Subsegments:

1) By Test Kits: Home Testing Kits, Laboratory Testing Kits

2) By Test Strips: Disposable Test Strips, Multi-Use Test Strips

3) By Other Product Types: Point-Of-Care Testing Devices, Cholesterol Monitors, Reagents And Calibration Solutions

Which Trends Are Impacting The Progress Of The Cholesterol Test Market?

Leading companies within the cholesterol test market are concentrating on developing innovative solutions, such as blood testing systems, aimed at improving the early detection and tracking of cholesterol levels, enhancing patient outcomes, enabling customized treatment plans, and supporting preventive healthcare initiatives. A blood testing system represents a comprehensive framework or platform utilized for analyzing blood samples to identify various components, markers, or conditions. For instance, in March 2024, Babson Diagnostics, Inc., an Austrelia-based healthcare technology startup, unveiled the BetterWay system, an inventive blood testing solution that incorporates the MiniDraw device for collecting fingertip samples. This system warms the patient’s hand, gathers a pea-sized blood sample using a lancet-equipped device, and automates the sample preparation, including mixing and temperature regulation, before it is sent to Babson’s lab for analysis. BetterWay can assess cholesterol, blood cell counts, and liver, kidney, and thyroid function from a minimal blood volume, providing results in one to two days while boosting patient comfort and convenience. This approach effectively closes the gap between conventional lab-based testing and accessible point-of-care options, thereby advancing routine cholesterol monitoring.

Who Are The Companies Competing Within The Cholesterol Test Market?

Major companies operating in the cholesterol test market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers GmbH, Fujifilm Holdings Corporation, CVS Health Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Mindray Medical International Limited, SYNLAB International GmbH, Beckman Coulter Inc., PerkinElmer Inc., Horiba Ltd., Sigma-Aldrich Corp, Randox Laboratories Ltd., Nova Biomedical Corp, Abcam plc, Sinocare Inc., ACM Global Laboratories, Clinical Reference Laboratory Inc., Sekisui Diagnostics LLC, Everlywell Inc., SpectraCell Laboratories Inc., LetsGetChecked USA, Ulta Lab Tests LLC, Cell Biolabs Inc., BioReference Health LLC, Diazyme Laboratories Inc.

Get The Full Cholesterol Test Market Report:

https://www.thebusinessresearchcompany.com/report/cholesterol-test-global-market-report

Which Region Has The Greatest Market Share In The Cholesterol Test Market?

North America was the largest region in the cholesterol test market in 2025. The regions covered in the cholesterol test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cholesterol Test Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cholesterol-test-global-market-report

Browse Through More Reports Similar to the Global Cholesterol Test Market 2026, By The Business Research Company

Lipid Panel Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/lipid-panel-testing-global-market-report

Poc Cholesterol Test Market 2026

https://www.thebusinessresearchcompany.com/report/poc-cholesterol-test-market

Low Density Lipoprotein Test Market Report 2026

https://www.thebusinessresearchcompany.com/report/low-density-lipoprotein-test-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795